Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 -12.57M
March 31, 2026 -10.52M
December 31, 2025 -10.86M
September 30, 2025 -10.46M
June 30, 2025 -7.620M
March 31, 2025 -6.736M
December 31, 2024 -0.4671M
September 30, 2024 -6.221M
June 30, 2024 -9.634M
March 31, 2024 -10.87M
December 31, 2023 -14.76M
September 30, 2023 -22.50M
June 30, 2023 -12.79M
March 31, 2023 17.08M
December 31, 2022 -6.255M
September 30, 2022 -4.734M
June 30, 2022 -7.156M
March 31, 2022 -5.667M
December 31, 2021 -8.449M
September 30, 2021 -4.008M
June 30, 2021 -5.016M
March 31, 2021 -4.781M
December 31, 2020 -10.01M
September 30, 2020 -16.16M
June 30, 2020 -4.383M
Date Value
March 31, 2020 -24.18M
December 31, 2019 -1.639M
September 30, 2019 -4.386M
June 30, 2019 -5.336M
March 31, 2019 -11.32M
December 31, 2018 -4.449M
September 30, 2018 -3.787M
June 30, 2018 -46.11M
March 31, 2018 -4.655M
December 31, 2017 -3.589M
September 30, 2017 -5.407M
June 30, 2017 -4.762M
March 31, 2017 -3.431M
December 31, 2016 -3.458M
September 30, 2016 -3.787M
June 30, 2016 -6.736M
March 31, 2016 -7.399M
December 31, 2015 -6.580M
September 30, 2015 -7.436M
June 30, 2015 -8.271M
March 31, 2015 -15.56M
December 31, 2014 -6.167M
September 30, 2014 -6.393M
June 30, 2014 -2.522M
March 31, 2014 -3.705M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Accuray, Inc. -1.353M
Micron Solutions, Inc. --
ResMed, Inc. -383.65M
Rockwell Medical, Inc. -0.487M
Microbot Medical, Inc. 4.471M